Contrast-enhanced mammography for ductal carcinoma in situ
Part of Cancer, Hormones & metabolism, Skin clinical trials.
This study tests whether adding a special type of mammogram with contrast dye to the standard mammogram helps doctors see the full extent of ductal carcinoma in situ (DCIS), a non-invasive breast cancer. This could lead to more accurate surgery planning and better outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ductal carcinoma in situ (DCIS) or microinvasive breast cancer after a breast biopsy.
- You are being treated at the Clinical Hospital Center in Rijeka and have been discussed by their multidisciplinary breast team.
- You are scheduled for surgery and the final pathology report will confirm DCIS or microinvasive disease only.
- You do not have any contraindications to contrast-enhanced mammography, such as kidney problems, iodine allergy, pregnancy, or thyroid issues.
- You have not had a breast MRI before surgery and have not had previous surgery on the same breast for invasive cancer.
- You are 18 years or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether contrast-enhanced mammography (a special mammogram with a dye injection) can help find breast cancers in women who have had breast cancer before and have dense breasts. You would get this test in addition to your normal screening, and it may offer better detection than ultrasound alone.
This study tests whether a special type of mammogram, called contrast-enhanced mammography (CEM), can better spot additional breast abnormalities that were seen on your MRI. It might help doctors decide on the best next steps without needing more invasive tests.
This study tests whether getting a contrast-enhanced mammogram (CEM) every two years is effective for detecting breast cancer in women who have had breast cancer before. If you qualify, you will receive CEM instead of a standard mammogram to see if it helps find cancer earlier.
This trial compares a special mammogram with dye (CEDM) to MRI for women already diagnosed with invasive breast cancer. The goal is to see if CEDM works as well as MRI for planning surgery, potentially offering a faster or easier option.
This trial tests whether doing a follow-up ultrasound after a special type of mammogram (contrast-enhanced mammography) can better understand extra breast spots that need more checking. It might help doctors give a clearer diagnosis.
This study tests how well a special mammogram with contrast can help assess breast cancer risk in women with dense breast tissue. It may help improve screening planning, especially when standard mammograms are harder to read due to density.
Hear when a new DCIS trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.